Sign in

CIK 0001503802

  • Non-accelerated filer
  • Smaller reporting company

Karyopharm Therapeutics Inc.

Sign in to watch
Tickers
KPTI KPTIQ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
263931704
Phone
+1 617-658-0600
Business address
85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA, 02459

Securities

  • KPTI Common stock Nasdaq
  • KPTIQ Common stock OTC
  1. 4 Open-market sale SVP, General Counsel&Secretary sold 3,971 shares at $0.72 ($2,866)
  2. 4 Open-market sale President and CEO sold 3,667 shares at $0.72 ($2,647)
  3. 4 Open-market sale EVP, CFO & Treasurer sold 7,050 shares at $0.72 ($5,089)
  4. 4 Open-market sale EVP & Chief Commercial Officer sold 5,356 shares at $0.72 ($3,866)
  5. 4 Open-market sale President and CEO sold 3,608 shares at $0.93 ($3,355)
  6. 4 Open-market sale EVP, Chief Development Officer sold 2,883 shares at $1.06 ($3,056)
  7. 4 Open-market sale President and CEO sold 3,616 shares at $0.85 ($3,077)
  8. 4 Open-market sale Director sold 818,044 shares at an average $0.96 ($785,027)
  9. 4 Open-market sale EVP, CFO & Treasurer sold 652 shares at $0.99 ($645)
  10. 4 Open-market sale President and CEO sold 3,592 shares at $0.99 ($3,556)
  11. 4 Open-market sale Director sold 906,178 shares at an average $0.97 ($880,693)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Open-market sale President and CEO sold 3,576 shares at $1.13 ($4,041)
  20. 4 Open-market sale EVP & Chief Medical Officer sold 6,789 shares at $1.17 ($7,943)

Page 5 of 31 · 601 filings